Lichen planus pemphigoides with predominant mucous membrane involvement: a series of 12 patients and a literature review

Front Immunol. 2024 Apr 15:15:1243566. doi: 10.3389/fimmu.2024.1243566. eCollection 2024.

Abstract

Background: Lichen planus pemphigoides (LPP), an association between lichen planus and bullous pemphigoid lesions, is a rare subepithelial autoimmune bullous disease. Mucous membrane involvement has been reported previously; however, it has never been specifically studied.

Methods: We report on 12 cases of LPP with predominant or exclusive mucous membrane involvement. The diagnosis of LPP was based on the presence of lichenoid infiltrates in histology and immune deposits in the basement membrane zone in direct immunofluorescence and/or immunoelectron microscopy. Our systematic review of the literature, performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, highlights the clinical and immunological characteristics of LPP, with or without mucous membrane involvement.

Results: Corticosteroids are the most frequently used treatment, with better outcomes in LPP with skin involvement alone than in that with mucous membrane involvement. Our results suggest that immunomodulators represent an alternative first-line treatment for patients with predominant mucous membrane involvement.

Keywords: autoimmune blistering dermatosis; autoimmune blistering disease; bullous pemphigoid; lichen planus pemphigoides; mucous membrane pemphigoid; oral lichen planus.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Lichen Planus* / diagnosis
  • Lichen Planus* / drug therapy
  • Lichen Planus* / immunology
  • Lichen Planus* / pathology
  • Male
  • Middle Aged
  • Mucous Membrane* / immunology
  • Mucous Membrane* / pathology
  • Pemphigoid, Bullous / diagnosis
  • Pemphigoid, Bullous / drug therapy
  • Pemphigoid, Bullous / immunology
  • Pemphigoid, Bullous / pathology

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.